BriaCell Therapeutics Corp. – NASDAQ:BCTXW

BriaCell Therapeutics Corp. stock price today

$0.026
-0.25
-90.59%
Financial Health
0
1
2
3
4
5
6
7
8
9

BriaCell Therapeutics Corp. stock price monthly change

+115.37%
month

BriaCell Therapeutics Corp. stock price quarterly change

+115.37%
quarter

BriaCell Therapeutics Corp. stock price yearly change

-87.16%
year

BriaCell Therapeutics Corp. key metrics

Market Cap
5.15M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
-0.03
PEG ratio
N/A
EPS
101.70
Revenue
N/A
EBITDA
-41.33M
Income
-16.89M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

BriaCell Therapeutics Corp. stock price history

BriaCell Therapeutics Corp. stock forecast

BriaCell Therapeutics Corp. financial statements

BriaCell Therapeutics Corp. (NASDAQ:BCTXW): Profit margin
Apr 2023 0 -4.89M
Jul 2023 0 -2.41M
Jan 2024 0 -11.29M
Apr 2024 0 1.71M
BriaCell Therapeutics Corp. (NASDAQ:BCTXW): Debt to assets
Apr 2023 29721868 35.61M 119.82%
Jul 2023 27163577 30.94M 113.91%
Jan 2024 12231047 20.54M 168%
Apr 2024 6203266 12.43M 200.48%
BriaCell Therapeutics Corp. (NASDAQ:BCTXW): Cash Flow
Apr 2023 -5.33M 0 1.59K
Jul 2023 -10.91M 0 4M
Jan 2024 -7.40M 0 0
Apr 2024 -5.08M -225K 0

BriaCell Therapeutics Corp. alternative data

BriaCell Therapeutics Corp. (NASDAQ:BCTXW): Employee count
Jan 2024 16
Feb 2024 16
Mar 2024 16
Apr 2024 16
May 2024 16
Jun 2024 16
Jul 2024 16

BriaCell Therapeutics Corp. other data

  • What's the price of BriaCell Therapeutics Corp. stock today?

    One share of BriaCell Therapeutics Corp. stock can currently be purchased for approximately $0.03.

  • When is BriaCell Therapeutics Corp.'s next earnings date?

    Unfortunately, BriaCell Therapeutics Corp.'s (BCTXW) next earnings date is currently unknown.

  • Does BriaCell Therapeutics Corp. pay dividends?

    No, BriaCell Therapeutics Corp. does not pay dividends.

  • How much money does BriaCell Therapeutics Corp. make?

    BriaCell Therapeutics Corp. has a market capitalization of 5.15M.

  • What is BriaCell Therapeutics Corp.'s stock symbol?

    BriaCell Therapeutics Corp. is traded on the NASDAQ under the ticker symbol "BCTXW".

  • What is BriaCell Therapeutics Corp.'s primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of BriaCell Therapeutics Corp.?

    Shares of BriaCell Therapeutics Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does BriaCell Therapeutics Corp. have?

    As Jul 2024, BriaCell Therapeutics Corp. employs 16 workers.

  • What is BriaCell Therapeutics Corp.'s official website?

    The official website for BriaCell Therapeutics Corp. is briacell.com.

  • How can i contact BriaCell Therapeutics Corp.?

    BriaCell Therapeutics Corp. can be reached via phone at +60 4 921 1810.

BriaCell Therapeutics Corp. company profile:

BriaCell Therapeutics Corp.

briacell.com
Exchange:

NASDAQ

Full time employees:

16

Industry:

Biotechnology

Sector:

Healthcare

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Bellevue Centre
West Vancouver, V7T 2X1

CIK: 0001610820
ISIN: CA10778Y1126
: